Novo Nordisk Blocks Ex-Lead's Use Of Alleged Trade Secrets
Novo Nordisk secured an injunction Thursday preventing an ex-strategy lead from using for profit or disclosing emails containing information the pharmaceutical company alleges could seriously damage its business, after a London...To view the full article, register now.
Already a subscriber? Click here to view full article